ACE Inhibitors | substances that lower blood pressure by inhibiting the Angiotensin-Converting Enzyme |
Agonist | substance that binds a receptor to create a biological effect normally seen at that receptor |
Antagonist | substance that binds a receptor to inhibit the biological response normally seen at that receptor |
ARBs | substances that lower blood pressure by inhibiting the angiotensin II receptor |
Pharmacodynamics | study of the effects a drug has on the body |
Pharmacogenomics | study of how a living organism's unique genetics affects their response to drugs |
Pharmacokinetics | study of how the body effects a drug |
Pharmacology | study of how substances interact with and effect a living organism |
Receptor | target that substance (drug) chemically binds to |
Schedule I | substances with no accepted medical use and a high potential for abuse |
Schedule II | drugs with accepted medical use but have a high potential for abuse leading to severe psychological or physical dependence |
Schedule III | drugs with accepted medical use with moderate to low potential for psychological or physical dependence |
Schedule IV | drugs with low potential for abuse and low potential for psychological or physical dependence |
Schedule V | drugs with lowest potential for abuse and lowest potential for psychological and physical dependence |